The Efficacy and Safety of Irinotecan Plus Temozolomide and Vincristine in Neuroblastoma with Brain Recurrence: A Retrospective Study

被引：0
|
作者：
Wang, J. [1 ]
Zhen, Z. [2 ]
Zhu, S. [3 ]
Lian, Z. [4 ]
Lu, S. [2 ]
Sun, F. [2 ]
Huang, J. [2 ]
Zhang, Y. [5 ]
Sun, X. [1 ]
机构：
[1] Sun Yat Sen Univ, Ctr Canc, Pediat Oncol, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Canc Ctr, Dept Pediat Oncol, Guangzhou, Peoples R China
[3] Capital Med Univ, Natl Ctr Childrens Hlth, Beijing Childrens Hosp, Med Oncol Dept, Beijing, Peoples R China
[4] Sun Yat Sen Univ, Ctr Canc, Pediat Oncol, Guangzhou, Peoples R China
[5] Sun Yat Sen Univ, Ctr Canc, Dept Pediat Oncol, Guangzhou, Peoples R China
来源：
PEDIATRIC BLOOD & CANCER | 2021年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PV0126
引用
收藏
页码：S213 / S214
页数：2
相关论文
共 50 条
  • [1] Vincristine, Irinotecan, and Temozolomide in Patients With Relapsed/Refractory Neuroblastoma
    Zhu, Jia
    Wang, Juan
    Sun, Feifei
    Zhen, Zijun
    Chen, Tingting
    Lu, Suying
    Huang, Junting
    Zhang, Yizhuo
    Sun, Xiaofei
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [2] Vincristine, irinotecan, and temozolomide in patients with relapsed and refractory neuroblastoma.
    Zhu, Jia
    Zhen, Zijun
    Wang, Juan
    Chen, Tingting
    Lu, Suying
    Sun, Feifei
    Huang, Junting
    Que, Yi
    Zhang, Lian
    Zhang, Yizhuo
    Sun, Xiaofei
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [3] Irinotecan plus temozolomide for relapsed or refractory neuroblastoma
    Kushner, Brian H.
    Kramer, Kim
    Modak, Shakeel
    Cheung, Nai-Kong V.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (33) : 5271 - 5276
  • [4] The efficacy and safety of vincristine, irinotecan and anlotinib in Epithelioid Sarcoma
    Lu Xie
    Xin Sun
    Jie Xu
    Xin Liang
    Kuisheng Liu
    Kunkun Sun
    Rongli Yang
    Xiaodong Tang
    Wei Guo
    BMC Cancer, 24
  • [5] Combination of bevacizumab plus irinotecan in recurrent malignant gliomas (MG): A retrospective study of efficacy and safety
    Gil Gil, M. J., Sr.
    Martinez-Garcia, M.
    Reynes, G.
    Costas, E.
    Fernandez-Chacon, C.
    Pernas, S.
    Benavides, M.
    Herrero, A.
    Perez-Martin, J.
    Balana, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [6] The efficacy and safety of vincristine, irinotecan and anlotinib in Epithelioid Sarcoma
    Xie, Lu
    Sun, Xin
    Xu, Jie
    Liang, Xin
    Liu, Kuisheng
    Sun, Kunkun
    Yang, Rongli
    Tang, Xiaodong
    Guo, Wei
    BMC CANCER, 2024, 24 (01)
  • [7] Phase II study of the combination of bevacizumab plus irinotecan and temozolomide for relapsed or refractory neuroblastoma (NB).
    Modak, Shakeel
    Kushner, Brian H.
    Kramer, Kim
    Leyco, Samantha
    Basu, Ellen M.
    Roberts, Stephen S.
    Cheung, Nai-Kong V.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [8] Efficacy of the VIT (vincristine, irinotecan and temozolomide) regimen in adults with metastatic Ewing sarcoma
    Dogan, Izzet
    Iribas, Ayca
    Ahmed, Melin Aydan
    Basaran, Mert
    JOURNAL OF CHEMOTHERAPY, 2023, 35 (04) : 343 - 347
  • [9] The efficacy and safety of irinotecan plus doxorubicin liposome in relapsed/refractory Wilms' tumors: A retrospective study.
    Wang, Juan
    Zhang, Lian
    Que, Yi
    Zhen, Zijun
    Zhu, Jia
    Sun, Feifei
    Lu, Suying
    Huang, Junting
    Wu, Liuhong
    Cai, Ruiqing
    Zhang, Yizhuo
    Sun, Xiaofei
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [10] PHASE II STUDY OF THE COMBINATION OF BEVACIZUMAB PLUS IRINOTECAN AND TEMOZOLOMIDE FOR RELAPSED OR REFRACTORY NEUROBLASTOMA: PRELIMINARY RESULTS
    Modak, Shakeel
    Kushner, Brian H.
    Kramer, Kim
    Basu, Ellen
    Roberts, Stephen S.
    Cheung, Nai-Kong V.
    PEDIATRIC BLOOD & CANCER, 2012, 59 (06) : 1057 - 1057
12345